Annual Shareholders Equity
$57.02 M
-$66.15 M-53.70%
31 December 2023
Summary:
Oncology Institute annual stockholders equity is currently $57.02 million, with the most recent change of -$66.15 million (-53.70%) on 31 December 2023. During the last 3 years, it has risen by +$28.92 million (+102.93%). TOIIW annual shareholders equity is now -53.70% below its all-time high of $123.17 million, reached on 31 December 2022.TOIIW Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$15.48 M
-$13.72 M-46.99%
30 September 2024
Summary:
Oncology Institute quarterly stockholders equity is currently $15.48 million, with the most recent change of -$13.72 million (-46.99%) on 30 September 2024. Over the past year, it has dropped by -$56.37 million (-78.45%). TOIIW quarterly shareholders equity is now -88.27% below its all-time high of $132.00 million, reached on 31 March 2022.TOIIW Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOIIW Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.7% | -78.5% |
| 3 y3 years | +102.9% | - |
| 5 y5 years | - | - |
TOIIW Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -53.7% | +102.9% | -88.3% | at low |
| 5 y | 5 years | -53.7% | +102.9% | -88.3% | at low |
| alltime | all time | -53.7% | +102.9% | -88.3% | at low |
Oncology Institute Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.48 M(-47.0%) |
| June 2024 | - | $29.21 M(-29.3%) |
| Mar 2024 | - | $41.30 M(-27.6%) |
| Dec 2023 | $57.02 M(-53.7%) | $57.02 M(-20.6%) |
| Sept 2023 | - | $71.85 M(-27.0%) |
| Mar 2023 | - | $98.41 M(-20.1%) |
| Dec 2022 | $123.17 M | $123.17 M(-3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $127.93 M(+3.2%) |
| June 2022 | - | $123.98 M(-6.1%) |
| Mar 2022 | - | $132.00 M(+26.7%) |
| Dec 2021 | $104.16 M(+270.7%) | $104.16 M(+106.6%) |
| June 2021 | - | $50.40 M(+79.4%) |
| Dec 2020 | $28.10 M(-33.4%) | $28.10 M |
| Dec 2019 | $42.22 M | - |
FAQ
- What is Oncology Institute annual stockholders equity?
- What is the all time high annual shareholders equity for Oncology Institute?
- What is Oncology Institute annual shareholders equity year-on-year change?
- What is Oncology Institute quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Oncology Institute?
- What is Oncology Institute quarterly shareholders equity year-on-year change?
What is Oncology Institute annual stockholders equity?
The current annual shareholders equity of TOIIW is $57.02 M
What is the all time high annual shareholders equity for Oncology Institute?
Oncology Institute all-time high annual stockholders equity is $123.17 M
What is Oncology Institute annual shareholders equity year-on-year change?
Over the past year, TOIIW annual stockholders equity has changed by -$66.15 M (-53.70%)
What is Oncology Institute quarterly stockholders equity?
The current quarterly shareholders equity of TOIIW is $15.48 M
What is the all time high quarterly shareholders equity for Oncology Institute?
Oncology Institute all-time high quarterly stockholders equity is $132.00 M
What is Oncology Institute quarterly shareholders equity year-on-year change?
Over the past year, TOIIW quarterly stockholders equity has changed by -$56.37 M (-78.45%)